Core Laboratories (CLB) Other Non-Current Liabilities (2022 - 2026)

Core Laboratories has reported Other Non-Current Liabilities for 5 years, with the latest figure at $15.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 24.41% year-over-year to $15.9 million; the trailing twelve-month figure through Mar 2026 stood at $15.9 million (down 24.41% YoY), and the FY2025 full-year result was $15.8 million, down 23.56% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $15.9 million, roughly flat from $15.8 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $21.9 million in Q2 2025, with the low at $15.8 million in Q4 2025.
• Historically, Other Non-Current Liabilities has averaged $19.7 million across 5 years, with a median of $20.2 million in 2024.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities grew 7.59% — and 2026, when it retreated 24.41%.
• Core Laboratories' Other Non-Current Liabilities stood at $20.9 million in 2022, then fell by 4.04% to $20.0 million in 2023, then rose by 3.45% to $20.7 million in 2024, then slipped by 23.56% to $15.8 million in 2025, then gained by 0.13% to $15.9 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $15.9 million (Q1 2026), $15.8 million (Q4 2025), and $21.4 million (Q3 2025), per Business Quant data.